Circumvent
Utilizing monogenic disorders to inform and solve highly complex…
- Employees
- 1–10
- Total Funding
- $495K
- Last Round
- $495K SeedOct 2021
- Rounds
- 2
About
Utilizing monogenic disorders to inform and solve highly complex…
Summary
Circumvent is a Biotech company. It has raised $495K in total across 2 rounds, most recently a $495K Seed round in Oct 2021. Investors include HHS NIH SBIR Phase II, Y Combinator Continuity Fund and Heritage Provider Network.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Neuralink is building a brain-computer interface for medical needs and greater human potential.
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.